Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer

BACKGROUND: Although therapeutic advances have led to enhanced survival in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, detection of residual disease remains challenging. Here, we examine two approved anti-HER2 monoclonal antibodies (mAbs), trastuzumab and pe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Imaging
Main Authors: AghaAmiri, Solmaz, Simien, Jo, Thompson, Alastair M., Voss, Julie, Ghosh, Sukhen C., Hernandez Vargas, Servando, Kim, Sarah, Azhdarinia, Ali, Tran Cao, Hop S.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8205604/
https://ncbi.nlm.nih.gov/pubmed/34194285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5540569
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares